250 related articles for article (PubMed ID: 11419032)
1. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
[TBL] [Abstract][Full Text] [Related]
2. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
3. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
4. [Ultrasound screening for Down's syndrome early in pregnancy: nuchal translucency thickness].
Müller MA; Pajkrt E; Bilardo CM
Ned Tijdschr Geneeskd; 2002 Apr; 146(17):793-8. PubMed ID: 12014236
[TBL] [Abstract][Full Text] [Related]
5. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
6. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
[TBL] [Abstract][Full Text] [Related]
7. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
8. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
9. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
[TBL] [Abstract][Full Text] [Related]
10. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
[TBL] [Abstract][Full Text] [Related]
12. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
[TBL] [Abstract][Full Text] [Related]
13. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
14. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
15. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
[TBL] [Abstract][Full Text] [Related]
16. First trimester nuchal translucency: effective routine screening for Down's syndrome.
Thilaganathan B; Sairam S; Michailidis G; Wathen NC
Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
[TBL] [Abstract][Full Text] [Related]
17. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
Saltvedt S; Almström H; Kublickas M; Valentin L; Bottinga R; Bui TH; Cederholm M; Conner P; Dannberg B; Malcus P; Marsk A; Grunewald C
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):537-45. PubMed ID: 15912479
[TBL] [Abstract][Full Text] [Related]
18. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
[TBL] [Abstract][Full Text] [Related]
19. The second-trimester fetal iliac angle as a sign of Down's syndrome.
Shipp TD; Bromley B; Lieberman E; Benacerraf BR
Ultrasound Obstet Gynecol; 1998 Jul; 12(1):15-8. PubMed ID: 9697278
[TBL] [Abstract][Full Text] [Related]
20. [Second trimester sonographic screening for Down's syndrome and other chromosomal abnormalities].
Dimitrova V; Chernev T; Mazneŭkova V; Simeonov E; Evtimova N
Akush Ginekol (Sofiia); 2002; 41(5):7-19. PubMed ID: 12440332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
